In patients with decompensated cirrhosis on diuretic therapy with tender gynaecomastia the best diuretic to substitute is:
**Core Concept**
Decompensated cirrhosis patients on diuretic therapy often experience electrolyte imbalances, particularly hypokalemia, which can exacerbate gynaecomastia due to potassium's role in aldosterone-mediated mineralocorticoid activity. The ideal diuretic substitution in this scenario should minimize further potassium loss and aldosterone-mediated effects.
**Why the Correct Answer is Right**
In patients with decompensated cirrhosis and gynaecomastia, loop diuretics like Furosemide (Option C) can worsen hypokalemia and exacerbate gynaecomastia. However, Thiazide diuretics (Option A) are not the best choice due to their potential for further potassium loss and increased aldosterone activity. The best option is to use a diuretic that minimizes potassium loss, such as a mild diuretic like Spironolactone (Option B). Spironolactone is a potassium-sparing diuretic that acts as a competitive antagonist of aldosterone, thereby reducing potassium loss and aldosterone-mediated effects.
**Why Each Wrong Option is Incorrect**
**Option A:** Thiazide diuretics (e.g., Hydrochlorothiazide) increase potassium loss in the urine, which can worsen hypokalemia and exacerbate gynaecomastia.
**Option B:** Not the best answer, as it is not a diuretic to substitute for the given scenario.
**Clinical Pearl / High-Yield Fact**
When managing patients with decompensated cirrhosis on diuretic therapy, it is essential to monitor potassium levels closely and consider potassium-sparing diuretics like Spironolactone to minimize further potassium loss and aldosterone-mediated effects.
**Correct Answer:** C. Furosemide is not the best answer, the correct answer is not among the options, the correct answer is likely **B. Spironolactone**